Gilead on Thursday disclosed that Trodelvy, the antibody-drug conjugate that is a key part of the drugmaker’s oncology business, failed a Phase 3 study after …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
For lung transplant recipients, exposure to higher air pollution levels was linked to an increased risk of death or graft failure, a retrospective cohort study
From our earliest days in the industry, AHN Biotechnologie GmbH has experienced much success with manufacturing equipment and consumables for laboratories around the world.
The effect of remote ischemic conditioning (RIC) on functional outcomes in patients with acute stroke.